Guanhao Biotech Co., Ltd. logo

Guanhao Biotech Co., Ltd. (300238)

Market Closed
11 Aug, 06:57
XSHE XSHE
¥
11. 87
-0.05
-0.4195%
¥
2.83B Market Cap
- P/E Ratio
- Div Yield
5.08M Volume
0.21 Eps
¥ 11.92
Previous Close
Add Transaction
Day Range
11.77 12.1
Year Range
10.19 18.3
Want to track 300238 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

300238 closed today lower at ¥11.87, a decrease of -0.4195% from yesterday's close, completing a monthly increase of 2.7706% or ¥0.32. Over the past 12 months, 300238 stock lost -19.8515%.
300238 is not paying dividends to its shareholders.
The last earnings report, released on Mar 26, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.0169%, based on the last three reports.
Guanhao Biotech Co., Ltd. has completed 2 stock splits, with the recent split occurring on Apr 16, 2015.
The company's stock is traded on one exchange.

300238 Chart

People also search for

Guangzhou Wondfo Biotech Co., Ltd.
¥ 17.74
-0.8385%
China Reform Health Management Co., Ltd.
¥ 7.42
-1.5915%
Acro Biosystems Co., Ltd.
¥ 82.3
+5.9202%
EIT Environmental Development Group Co., Ltd.
¥ 16.48
-1.3764%
Huapont Life Sciences Co., Ltd.
¥ 4.5
+0.6711%

Guanhao Biotech Co., Ltd. (300238) FAQ

What is the stock price today?

The current price is ¥11.87.

On which exchange is it traded?

Guanhao Biotech Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 300238.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 2.83B.

Has Guanhao Biotech Co., Ltd. ever had a stock split?

Guanhao Biotech Co., Ltd. had 2 splits and the recent split was on Apr 16, 2015.

Guanhao Biotech Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
Mr. Feng Zhao CEO
XSHE Exchange
CNE100001575 ISIN
CN Country
535 Employees
- Last Dividend
16 Apr 2015 Last Split
6 Jul 2011 IPO Date

Overview

Guanhao Biotech Co., Ltd. is a pioneering company established in 1999, with its headquarters based in Guangzhou, China. The company is dedicated to the development, manufacturing, and marketing of regenerative medicines and life sciences products. Operating primarily in China, Guanhao Biotech has carved a niche for itself in the field of medical sciences with a focus on regenerative medicine. The company leverages cutting-edge technology to create innovative products that are used in various medical specialties including neurosurgery, thoracic surgery, ophthalmology, dermatology, orthopedics, cosmetology, and more. Through its relentless pursuit of excellence and innovation, Guanhao Biotech aims to improve patient care and outcomes in multiple medical and surgical fields.

Products and Services

  • NormalGEN
  • A dura repair patch designed for use in neurosurgery. This product aims to provide a safe and effective solution for repairing the dura mater, a thick membrane that surrounds the brain and spinal cord.

  • GrandNeuro
  • Another dura repair patch, specifically tailored for applications in neurosurgery. GrandNeuro offers an alternative option for neurosurgeons seeking high-quality dura mater repair materials.

  • ThormalGEN
  • A surgical patch used in thoracic surgery. ThormalGEN is designed to meet the specific needs of thoracic procedures, providing support and promoting healing in thoracic structures.

  • DermalGEN
  • A wound dressing product suitable for applications in dermatology. DermalGEN is crafted to aid in the healing of various types of skin injuries, offering protection and support during the healing process.

  • IREAL breast patch
  • A product developed for use in cosmetology and plastic surgery, specifically for breast augmentation and reconstruction procedures. The IREAL breast patch is intended to improve post-operative recovery and outcomes.

  • Youvision corneal graft
  • An advanced product for use in ophthalmology, specifically designed for corneal transplantation. Youvision corneal graft aims to restore vision in patients with damaged or diseased corneas.

  • Intraocular lenses (License)
  • A range of intraocular lenses licensed for use in ophthalmic surgeries. These lenses are implanted to replace the eye's natural lens when it is removed during cataract surgery or to improve vision in cases of severe refractive errors.

Contact Information

Address: No. 12 Yuyan Road, Guangzhou, China, 510530
Phone: 86 20 3205 2806